Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Leukocytes01:27

Disorders of Leukocytes

1.0K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.0K
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

1.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.0K
Cerebrospinal Fluid01:21

Cerebrospinal Fluid

2.5K
Cerebrospinal fluid (CSF) is a colorless liquid that flows around the brain and the spinal cord, playing a vital role in the protection, support, and overall function of the central nervous system (CNS). CSF production, circulation, and absorption are tightly regulated processes essential for the brain and spinal cord to function properly.
CSF Production
CSF is produced mainly in the choroid plexus, a network of capillaries and ependymal cells located within the ventricular system of the brain....
2.5K
Autoimmune Disorders01:29

Autoimmune Disorders

585
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
585

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mind the gap: making headway in functional visual loss.

Eye (London, England)·2026
Same author

Infographic: efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity.

Eye (London, England)·2026
Same author

Spaceflight-associated neuro-ocular syndrome (SANS): expert consensus on diagnosis and management.

Eye (London, England)·2026
Same author

Infographic: efficacy and safety of intravitreal siRNA therapy for acute NAION (QRK207 trial).

Eye (London, England)·2026
Same author

Infographic: optic nerve decompression surgery for NAION (IONDT Trial).

Eye (London, England)·2026
Same author

Identifying MicroRNA Biomarkers in Idiopathic Intracranial Hypertension: A Pilot Study.

Neurology·2026

Related Experiment Video

Updated: Aug 9, 2025

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.9K

The UK CSF Disorders Day 2022.

Edward J Bilton1, Alexandra J Sinclair2,3,4, Susan P Mollan1,2

  • 1Birmingham Neuro-Ophthalmology, Queen Elizabeth Hospital,University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Neuro-Ophthalmology (Aeolus Press)
|February 17, 2023
PubMed
Summary

The UK Cerebrospinal Fluid Disorders meeting reconvened, highlighting multi-disciplinary approaches for these complex neurological conditions. Discussions focused on idiopathic intracranial hypertension and advances in intracranial pressure monitoring and treatment.

Keywords:
Idiopathic intracranial hypertensionheadacheintracranial pressureoptical coherence tomographyvision

More Related Videos

Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice
08:49

Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice

Published on: October 6, 2023

1.8K
Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

1.8K

Related Experiment Videos

Last Updated: Aug 9, 2025

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
07:08

A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status

Published on: October 20, 2016

7.9K
Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice
08:49

Simultaneous Isolation of Principal Central Nervous System-Resident Cell Types from Adult Autoimmune Encephalomyelitis Mice

Published on: October 6, 2023

1.8K
Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
09:43

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses

Published on: March 8, 2024

1.8K

Area of Science:

  • Neurology
  • Neurosurgery
  • Ophthalmology

Background:

  • Cerebrospinal fluid (CSF) disorders necessitate a collaborative, multi-disciplinary approach.
  • Neurological, neuro-ophthalmological, neuroradiological, and neurosurgical expertise are crucial for managing CSF disorders.
  • The annual United Kingdom meeting addresses these complex conditions.

Purpose of the Study:

  • To reconvene the annual United Kingdom Cerebrospinal Fluid Disorders meeting.
  • To present the latest advancements in understanding and treating CSF disorders.
  • To foster multi-disciplinary collaboration in neurosciences.

Main Methods:

  • The meeting featured presentations on current research and clinical practices.
  • Discussions encompassed the newest concepts in idiopathic intracranial hypertension (IIH) pathophysiology.
  • Advances in intracranial pressure monitoring and treatment strategies were reviewed.

Main Results:

  • The meeting successfully reconvened, facilitating knowledge exchange.
  • Newest concepts in idiopathic intracranial hypertension pathophysiology were shared.
  • Recent advances in intracranial pressure monitoring and treatment were presented.

Conclusions:

  • Multi-disciplinary collaboration is essential for managing cerebrospinal fluid disorders.
  • The meeting highlighted significant progress in understanding and treating conditions like IIH.
  • Continued advancements in monitoring and treatment offer improved patient care strategies.